Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 4
1980 2
1981 2
1982 2
1983 4
1984 1
1985 2
1986 3
1987 3
1988 3
1989 6
1990 1
1991 4
1992 4
1993 8
1994 5
1995 3
1996 5
1997 1
1998 9
1999 3
2000 11
2001 7
2002 8
2003 3
2004 8
2005 8
2006 9
2007 8
2008 2
2009 10
2010 10
2011 8
2012 8
2013 8
2014 15
2015 6
2016 10
2017 13
2018 8
2019 10
2020 8
2021 12
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Ruzzi F, Semprini MS, Scalambra L, Palladini A, Angelicola S, Cappello C, Pittino OM, Nanni P, Lollini PL. Ruzzi F, et al. Among authors: nanni p. Int J Mol Sci. 2023 Aug 19;24(16):12963. doi: 10.3390/ijms241612963. Int J Mol Sci. 2023. PMID: 37629147 Free PMC article. Review.
The Promise of Preventive Cancer Vaccines.
Lollini PL, Cavallo F, Nanni P, Quaglino E. Lollini PL, et al. Among authors: nanni p. Vaccines (Basel). 2015 Jun 17;3(2):467-89. doi: 10.3390/vaccines3020467. Vaccines (Basel). 2015. PMID: 26343198 Free PMC article. Review.
Preclinical vaccines against mammary carcinoma.
Lollini PL, Cavallo F, De Giovanni C, Nanni P. Lollini PL, et al. Among authors: nanni p. Expert Rev Vaccines. 2013 Dec;12(12):1449-63. doi: 10.1586/14760584.2013.845530. Expert Rev Vaccines. 2013. PMID: 24195482 Free article. Review.
Oncolytic herpes virus retargeted to HER-2.
Lollini PL, Menotti L, De Giovanni C, Campadelli-Fiume G, Nanni P. Lollini PL, et al. Among authors: nanni p. Cell Cycle. 2009 Sep 15;8(18):2859-60. doi: 10.4161/cc.8.18.9368. Epub 2009 Sep 26. Cell Cycle. 2009. PMID: 19729994 No abstract available.
IFN-γ and CD38 in Hyperprogressive Cancer Development.
Angelicola S, Ruzzi F, Landuzzi L, Scalambra L, Gelsomino F, Ardizzoni A, Nanni P, Lollini PL, Palladini A. Angelicola S, et al. Among authors: nanni p. Cancers (Basel). 2021 Jan 15;13(2):309. doi: 10.3390/cancers13020309. Cancers (Basel). 2021. PMID: 33467713 Free PMC article. Review.
Cancer immunoprevention: from mice to early clinical trials.
Palladini A, Landuzzi L, Lollini PL, Nanni P. Palladini A, et al. Among authors: nanni p. BMC Immunol. 2018 Jun 15;19(1):16. doi: 10.1186/s12865-018-0253-0. BMC Immunol. 2018. PMID: 29902992 Free PMC article. Review.
Cancer immunoprevention.
Lollini PL, De Giovanni C, Pannellini T, Cavallo F, Forni G, Nanni P. Lollini PL, et al. Among authors: nanni p. Future Oncol. 2005 Feb;1(1):57-66. doi: 10.1517/14796694.1.1.57. Future Oncol. 2005. PMID: 16555976 Review.
Molecular and cellular biology of rhabdomyosarcoma.
De Giovanni C, Landuzzi L, Nicoletti G, Lollini PL, Nanni P. De Giovanni C, et al. Among authors: nanni p. Future Oncol. 2009 Nov;5(9):1449-75. doi: 10.2217/fon.09.97. Future Oncol. 2009. PMID: 19903072 Review.
Cytokine gene therapy: hopes and pitfalls.
Nanni P, Forni G, Lollini PL. Nanni P, et al. Ann Oncol. 1999 Mar;10(3):261-6. doi: 10.1023/a:1008304721889. Ann Oncol. 1999. PMID: 10355568 Free article. Review.
New target antigens for cancer immunoprevention.
Lollini PL, Nicoletti G, Landuzzi L, De Giovanni C, Nanni P. Lollini PL, et al. Among authors: nanni p. Curr Cancer Drug Targets. 2005 May;5(3):221-8. doi: 10.2174/1568009053765762. Curr Cancer Drug Targets. 2005. PMID: 15892621 Review.
266 results